The 3-year axillary RFS rate was 99.2% with axillary lymph node dissection and 98.8% with less-invasive procedures. Less-invasive lymph node procedures are noninferior to axillary lymph node ...
Less invasive procedures like TAD, SLNB, and TLNB show noninferiority to ALND in axillary recurrence-free survival for breast cancer patients post-NACT. The study's 3-year data indicate comparable ...
The role of postmastectomy chest-wall irradiation in patients with breast cancer classified as pN1 (with involvement of one to three axillary nodes) or pN0 (pathologically node negative) with ...
Patients with early-stage, node-positive breast cancer whose nodes are pathologically tumor-free (ypN0) after neoadjuvant chemotherapy may safely skip post-mastectomy nodal irradiation without ...
Objective: To evaluate the value of the clinical model for predicting axillary lymph node metastasis (ALNM) of breast cancer before operation by integrating ultrasound (US) and ...
D. Scott Lind, M.D., F.A.C.S.; Barbara L. Smith, M.D., Ph.D., F.A.C.S.; Wiley W. Souba, M.D., Sc.D., F.A.C.S. Before the advent of SLN biopsy, axillary dissection was ...
Recent results from the NRG-NSABP B-51/RTOG 1304 clinical study showed that the addition of regional nodal irradiation (RNI) does not decrease the rates of invasive breast cancer recurrence in ...
A study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to ...
Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...
Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments. Misconceptions about lymphedema precautions, such as avoiding blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback